9th Annual Biomarkers Congress

Oncology: Merck

Total Score People Score Events Score
46 41 31
Date Event Presentation Speakers
October 7, 2013 Drug Discovery Week Europe (DDWE) Using System Biology Biomarkers to Combat Mechanisms of Disease Alain van Gool
September 12, 2013 The 2nd International Conference on Genomics in the Americas Integration of NGS Into Early Clinical Development in Oncology James Watters
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Preclinical Development of RNA Therapeutics Michael Flanagan
microRNA mimics and diagnostics Lee P. Lim
May 19, 2010 Towards Personalized Cancer Medicine Integrative Genomic Models of Disease, Use of Contributor Networks Stephen H Friend
SESSION IV: Biomarkers for Prognosis/Response: Impact on Clinical Trials Stephen H Friend
Molecular Profiling of Pre-Clinical and Clinical Models: Informing the Development of Rational Combinations James Watters
PANEL DISCUSSION Stephen H Friend
May 4, 2010 Biomarker World Congress 2010 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
April 30, 2010 Drug Story Dll4 and Notch1 Antagonist Antibodies Inhibit Yan Wu
February 22, 2010 2010 PERSONALIZED MEDICINE PARTNERSHIPS CONFERENCE Merck’s Licensing Strategy – Oncology Partnerships and Personalized Medicine Linda Egger
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Case Presentation 3: Second-Line and Third-Line Brendan O’Neill
Session 3: Advanced Colorectal Cancer Brendan O’Neill
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Proteomics - From Basic Research to the Clinic Ronald C. Hendrickson
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Missing Data Mechanisms in a Dose Finding Adaptive Trial Kenneth Liu
August 10, 2009 Second Annual Trends in Cancer Diagnostics Cancer Biomarkers to Predict Therapeutic Response Cynthia Gawron-Burke
August 3, 2009 Oligonucleotide Therapeutics - From Concept to Implementation Agenda RNA Therapeutics - Are We Leveraging on the Promise? Paul Burke
June 9, 2009 Cell and Tissue-Based Assays for HTS Data Analysis in RNAi High-Throughput Screens Xiaohua Douglas Zhang
Evaluation of Putative GPCR Antagonists Using the CellKey System David J. Bell, Department of Automated Biotechnology, Merck & Company David J. Bell
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Inward Rectifier Kir2.1 PatchXpress Assay as a Model of Cardiac IK1 John P. Imredy
March 9, 2009 Drug Development Latin America Organizer’s Welcome and Chairperson’s Remarks Jorge Rodriguez Larrain
Chairperson’s Remarks Jorge Rodriguez Larrain
Adaptative Designs (Phase I - III): Regulatory Challenges and Opportunities in Latin America Jorge Rodriguez Larrain
January 26, 2009 7th Annual Partnering with Central Labs Track B : Utility of Imaging in Clinical Trials- Strategies for Success P David Mozley
Track B : Building the Imaging Lexicon for Rate Cards to Improve Industry Consistency P David Mozley
PANEL DISCUSSION : Comparing Approaches: Preferred Providers vs Competitive Bidding, What is your Best Choice? Diane Stinson
January 5, 2009 High Content Analysis Insight into HCS Data Stream: Analytical Strategy and Applications Ansuman Bagchi
Statistical Analysis of High-Content Data: Harnessing the Full Data Matrix Amir A Handzel
High-Throughput High-Content Screening in Primary and Stem Cells Francesca Santini
November 17, 2008 BIO-Europe 2008 Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier-Stage Collaborations? Barbara Yanni, Bernhard Kirschbaum
September 29, 2008 Genomic Biomarkers Building a Biomarker Information Pipeline and Enabling Translational and Personalized Medicine: Leveraging Industry Standards to Bring Omics Closer to Medicine Martin D. Leach
Pharmacogenomics Data: Transmission and Submission Joyce Hernandez
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Decision-Making in Oncology Drug Development Stephen H Friend
Panel Discussion Stephen H Friend
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Keynote Address: Chinese SFDA and Global Drug Development - Quality, Science and Speed Zili Li
Elective: Track A: Novel Advancements and Developments Originating in China: Engineering Anti-ADDLs Antibodies for Treatment of Alzheimers Disease Zhiqiang An
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
March 31, 2008 China 2008 Pharmaceutical R&D Summit Track I Discovery to PreClinical Development –Case studies of Licensing & Partnering in China Chairperson’s Opening Remarks Dr. Bharatt M. Chowrira
March 25, 2008 PATHWAY ANALYSIS Innovative Medicines for Europe Phil Hewitt
March 25, 2008 CANCER MOLECULAR MARKERS Chairperson’s Remarks Huseyin Mehmet
March 25, 2008 TRENDS IN DRUG SAFETY Innovative Medicines for Europe Phil Hewitt
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Applications of Molecular Profiling to RNA Therapeutics Aimee L Jackson
February 19, 2008 Screening Europe Track A Neglected Diseases: Building a Lead Discovery Engine Dominique Perrin
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Pre-Clinical Imaging (08:25-12:15) John Atack
Pre-Clinical Imaging: PET Imaging and Occupancy Measurements in Rat, Monkey and Humans (08:30-09:00) John Atack
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: LAYING THE GROUND WORK FOR EARLY DECISION MAKING (13:45 - 19:00) Jerald S. Schindler
SESSION I: Co-Chairperson’s Opening Remarks (13:50 - 14:00) Jerald S. Schindler
SESSION II: REGULATORY PERSPECTIVES AND LESSONS LEARNED FROM CONDUCTING STUDIES WITH ADAPTIVE TRIAL DESIGNS (08:30-11:15) Jerald S. Schindler
SESSION II: FDA's Perspective on Adaptive Trial Designs (09:15-09:45) Jerald S. Schindler
CASE STUDIES (11:15-14:45) Xiaoyin Frank Fran
CASE STUDY: A Phase 2b Adaptive Dose-Finding Trial of a Novel Compound to Treat Acute Migraines (15:45-16:15) Xiaoyin Frank Fran
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Thomas A. Miller
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Histone Deacetylase Inhibitors: Bench to Bedside (08:40-09:10) Thomas A. Miller
Roundtable Discussion Sessions - Topic: HDAC Inhibitors and Drug Selectivity Issues (07:30-08:30) Thomas A. Miller
Keynote Session: Executive Panel: Delivering Drugs for Difficult Targets(08:40-09:40) Lex Van der Ploeg, Shama Kajiji
NEXT GENERATION HDAC INHIBITORS: Structural Biology of Human Histone Deacetylase Enzymes (11:10-11:40) Andrea Carfi
NEXT GENERATION HDAC INHIBITORS (10:35-12:40) Thomas A. Miller, Andrea Carfi
NEXT GENERATION HDAC INHIBITORS: Chairperson’s Remarks (10:35-10:40) Thomas A. Miller
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.